Search Results - "Gray, John Dixon"

Development of an Allogeneic Anti-Bcma T Cell Therapy Utilizing a Novel Dimeric Antigen Receptor (DAR) Structure by Ding, Bei Bei, Gray, John Dixon, Zhang, Nan, Zhang, Yanliang, Cao, Xia, Krapf, Irina, Deng, Qingdong Mark, Wei, Angel, Zeldis, Jerome B., Knight, Robert D., Kaufmann, Gunnar F., Ji, Henry, Guo, Wenzhong

“…Background: Multiple myeloma remains an incurable malignancy of plasma cells. Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a…”
Get full text

Development of a Genetically-Engineered Allogeneic Anti-CD38 T Cell Therapy Utilizing a Novel Antigen Receptor Structure by Ding, Bei Bei, Gray, John Dixon, Krapf, Irina, Zhang, Yanliang, Zhang, Nan, Deng, Qingdong Mark, Wei, Angel, Knight, Robert D., Zeldis, Jerome B., Kaufmann, Gunnar F., Ji, Henry, Guo, Wenzhong

“…Background: Autologous Chimeric Antigen Receptor (CAR) T cell therapy has shown great promise as a treatment modality for a variety of hematological…”
Get full text

Properties of TNFR2, PDL-1 dependent human CD8+ regulatory cells generated ex-vivo that can be strongly protective in vivo (116.4) by Horwitz, David, Pan, Stephanie, Wang, Ju Hua, Lan, Qin, Zheng, Song Guo, Gray, John Dixon

“…Abstract In addition to CD4+CD25+Foxp3+ Tregs, natural and induced CD8+ Tregs have been described. Here we report our progress in generating human CD8+ Tregs…”
Get full text